BioMark Diagnostics - Founder and CEO, Rashid Bux

" BioMark Diagnostics (CSE:BUX) and the Icahn School of Medicine announce partnership on lung cancer screening

BioMark Diagnostics (BUX) and the Icahn School of Medicine at Mount Sinai in New York have signed a research agreement to collaborate on
BioMark Diagnostics - Founder and CEO, Rashid Bux

" BioMark Diagnostics (CSE:BUX) closes $1.5 million financing round

BioMark Diagnostics (BUX) has closed a non-brokered private placement for gross proceeds of $1,265,500.
BioMark Diagnostics - Founder and CEO, Rashid Bux

" BioMark (CSE:BUX) receives $825K grant for lung cancer research

BioMark Diagnostics (BUX) has received an C$825,000 grant to develop its liquid biopsy assay for early-stage lung cancer screening.